Syra Health, a healthcare technology company that provides tools to analyze population health, is investing $275,000 over a five-year period to examine the City of San Antonio’s implementation of the Racial and Ethnic Approaches to Community Health (REACH) project. announced that they had signed a dollar contract.
The U.S. Department of Health and Human Services (HHS) The REACH Project is a national program managed by the Centers for Disease Control and Prevention (CDC).
Adopted by the City of San Antonio, this program expands HHS’s Healthy Neighborhoods Program to reduce racial and ethnic health disparities, including chronic conditions, among specific populations in rural, urban, and tribal communities with high disease burdens. The purpose is to
In San Antonio, REACH works to improve safe and accessible physical activity, adult vaccines, food security, and early education among Latino and African American communities on the city’s South, West, and East Sides. It aims to promote standards in the care setting.
Syra Health will leverage its technology to assess and advise cities on the scalability, impact, and sustainability of strategies related to REACH projects.
The Indiana-based company’s population health tools include health equity analytics solutions and epidemiology-focused products. The company also provides analytics for identifying and addressing social determinants of health using data from a variety of resources that monitor and track health outcomes.
“The nation’s focus on improving the health of its people presents an exciting opportunity for Shira Health,” Sandeep Alam, chairman and president of Shira Health, said in a statement. “We are proud to be part of the solution, helping our state government partners strive to achieve a healthier population in and for their people.”
bigger trends
Earlier this month, Syra 2 year contract A total of approximately approximately We provided funding valued at $215,000.
Founded just three years ago, the healthcare services company began trading on the Nasdaq in September. stock price It used to be $3 per share, but as of today, it’s down to $1.30 per share.
in File with SEC Regarding risks related to its business, the company said in May that it had “earned approximately $5.3 million in revenue as of December 31, 2022, and approximately $1.3 million in revenue as of December 31, 2021, but future profitability is uncertain.” It’s unclear,” he said.
Still, the company hopes to “become a leader in clinical healthcare solutions” by collaborating with the public and private healthcare sectors. The company also said it expects growth and plans to expand its business by acquiring companies that provide similar services.
Other companies offering analytics for people’s health include healthcare data companies Komodo Health and data-focused population health analytics company Innovaccer.